Monday, May 25, 2009

M.Tech(Nano) Interaction Programme 2009 in Jamia Miilia Islamia



 Prof Mushahid Hussain
Co-ordinator, M.Tech(Nanotechnology) Prog'm
Dept of Physics,Jamia Millia Islamia,Delhi

 Sucessfully Done M.Tech (Nano) Projects Interaction Programme 2009

Date           : 23 May 2009

Venue        : Seminar Hall ,Dept of Physics, J.M.I

Timings     : 9.30 AM to 2.00 PM 

Organiser : Prof Mushahid Hussain

Masters of Technology was started in Department of Physics,Jamia Millia Islamia in 2007 and successfully continue till now.Now Final Year students of the 2007 Batch of this course is ready to get job/to do reasearch after specialized in this field.For this , the co-ordinator of M.Tech(Nanotechnology) organized a Interaction programme between the final Year and Previous Year students on 23 May .Beside this various scientist are also invited from NPL and DRDO who gave their lectures on different R&D  activities carried out in the field of Nanotechnology. 

Participating Delegates:-

From Jamia Milllia Islamia:-

Prof Syed Sajjad Mehndi (HoD,Dept of Physics) 

Prof Mushahid Hussain  (Co-ordinator-M.Tech(Nano) programme

Prof Mohd Abdul Wahab

Prof Mohd Zulfiqar Zulfiqar

Prof Ayub Khan,D.U (Guest faculty in JMI)

Dr Saeeduddin

Dr Azher Majid Siddique

Phd Scholors of JMI

M.Tech (Nano) Sudents of First and Second Year.


Participating  scientist of DRDO and NPL:

 Prof Krishnan Lal (Emiretus Scientist) ,Former Director NPL


Dr R.P Pant ,NPL

Dr M.N.Kamalasanan

Dr T.D Senguttuvan

Dr Sanjay Srivastava



 Synthesize and characteization of CNT and its Modelling and Simulation, 

Synthesize and Characterization of Zno Nanoparticles,  

Nanomagnetic Materials and its  Applications,

X-Ray Diffraction,Organic LEDs ,

NanoCeramics and its applictions ,

Silcon Nanowires,Purification Of CNT's


Thursday, May 21, 2009

DRDO Provides Good News for Cancer Patients Undergoing Radiotherapy

A new breakthrough by Defence Research and Development Organisation (DRDO)
may finally provide them some relief from the serious side effects of ionising radiation that's given to them during the treatment process. The DRDO has developed a herbal substitute for the "only effective'' but toxic chemical radio protector, given to patients to minimise the harmful
side effect of ionising radiations. The herbal radio protector is developed from two plants found in the Himalayan region. Following the encouraging pre-clinical trial results in animals, DRDO is all set to conduct human trials. "The herbal radio protector has no side effects and is found to give 100% protection against harmful side effects of ionising radiation. The only chemical radio protector available in the world is highly toxic. If human trials are successful, then it will replace the chemical radio protector. DRDO got the approval from Drug Controller General of India for human trials two months ago . The human trials will be conducted on cancer patients undergoing radiotherapy at Army Research and Referral Hospital and All India Institute of Medical Science (AIIMS). DRDO's main aim is to develop a herbal radio protector that can be given to ionising radiation victims in case of a nuclear war or accidental exposure. "In case of a nuclear attack or accidental radiation exposure, the rescue team can be given herbal radio protector to prevent them from radiations. The damages can be minimized in victims post-exposure. In animal trials, we have seen that it can protect up to 6 gray,'' Beside this ,ionising radiation exposure during one radiotherapy session is 2 gray. source of the herbal radio protector are two herbal plants---Podophyllum .The two plants Hexandrum and Hippophae rhamnoides are found in the Himalayan region and are said to be rich source of anti-oxidants. "During radiotherapy a lot of free radicals are formed in the body which can have damaging effect on other body parts. The herbal radio protector will release anti-oxidants and remove free radicals thereby reducing oxidative stress.

DRDO has been working on the project for the past five years and has successfully conducted all the safety, efficacy and dose calculation trials. It has spent close to Rs 80 lakh on the project.

Thursday, May 7, 2009


Dr Kiran Bala Narula
M.D, DM (Neurology)
Addl Professor & HoD Neurology, IHBAS, Delhi

Dr Kiran Bala is one of the dedicated Neurologist in the field of Patient Care Services dealing with Neurological Disorder diagonosis Like Various Epileptic Disorders,Cerebal palsy,Dementia and Alzheimers ,Multiple Scelerosis,Meningitis,Neurofibroma,Menigogocelle ,Mental Retardation ,Headache,Strokes ,Nerve/Muscles fibres problem which associated with the neurological problems etc.She got the Diploma of National Board in Neurology in 1996 and Become DM in this field in 1998.Since she was continue to give her services as a Assistant Professor to till now in IHBAS.She also connected with different NGO's who working in the Health Care Sector and Social Cause Like Janki Foundation,Brahma Kumari etc.Beside this , she is a member of various Neurological Association like DNA,Neurlogy India,INA ,WHO etc. Her Research Papers,Posters Presentations , Articles regarding Neuro Disorders published in various National and International journals.

Presently she giving her services as a HoD and Additional Professor in Neurology Department of Institute of Human Behaviour and Allied Sciences,Dilshad Garden Delhi.IHBAS is a premier reputed Institute of Northern India dealing with different Neuro ,Psychitaric and Psychological problems. Now Neuro Surgery Also start in this Institute which having high tech Operation Theatres with Miniaturized instruments required for the surgery.Institute is well equipped with different Clinical Labs like Neuro-Electrophysiology Lab,Neuro-Pharmacology lab,Neuro-Bio Chemistry lab , Neuro Pathology Lab ,Neuro Radiology lab with Good quality X-Rays and Ultrasonography and Color Doppler etc .These labs having high tech microscopes for the characteization of Blood , Urine ,Stool and Cough/Saliva Samples and Instruments for sensing the Epileptiform Discharges .Beside this Institue is well Equipped with high power 3 Tesla MRI whcih give the better contrast of Soft Tissues than any other MRI . This high power MRI facility available at only few places in Delhi.It created around 30,000 guass magnetic field which is more than earth Magnetic Field and resulting in the enhance contrast

Some of her achievements/published Research Papers regarding Neuro-Diagonosis listed Below:-

Quackery Masquerading as Complementary and Alternative Medicine (CAM) in Patients With Epilepsy

Vascular risk factors for Alzheimer diseaseAlzheimer's and Dementia

Post-traumatic dissecting aneurysms of bilateral cervical carotid arteries with delayed complications


The Lennox-Gastaut syndrome is very serious but uncommon.

Three basic features define it:

Generalized seizures of more than one type, which are difficult to control .Slowness of intellectual growth and associated personality difficulties .A specific EEG abnormality called a slow spike-and-wave pattern, found when the child is awake, and generalized fast rhythms during sleep

Who gets it?

The seizures usually begin in children between 2 and 6 years of age, but they can start a little earlier or later. Many of the children who develop Lennox-Gastaut syndrome have a pre-existing brain disorder or injury. About one-third previously had infantile spasms with an underlying brain disorder (also known as symptomatic West syndrome).

More About L.G.Syndrome:-

Three kinds of seizures that usually occur in Lennox-Gastaut syndrome are tonic, atonic (also known as akinetic), and atypical absence seizures. Tonic seizures tend to be the most common seizure type and are especially frequent when the child sleeps. Some children also have other types, such as myoclonic, partial or tonic-clonic seizures. Because "drop attacks" (atonic or tonic seizures) in which the child falls suddenly are common, many of these children need a helmet and facemask to prevent injury.

A few children do well, but most (75-95%) with the Lennox-Gastaut syndrome have intellectual impairment that ranges from mild to severe.

Behavioral problems are also common. They probably have several causes:

the brain injury
frequent seizures
lack of normal social stimulation
side effects from seizure medicines

Status epilepticus (a state of continuous seizure activity) affects about 90% of those with Lennox-Gastaut syndrome. It is very important to recognize and treat it. A long convulsive seizure is usually easy to recognize. But children with Lennox-Gastaut syndrome most often have non-convulsive status epilepticus, which can be very difficult to recognize. The child may be described as confused, irritable, tired, or apathetic. Parents and teachers often think that the child is ill, experiencing side effects from medicine, or just lonely and bored.

How is it treated?

Medications that are useful for controlling the seizures of patients with Lennox-Gastaut syndrome include:

Depakote (valproate)
Frisium (clobazam, not available in the US)
Topamax (topiramate)
Lamictal (lamotrigine)
Felbatol (felbamate) is also effective and often can improve behavior and quality of life, but it has a high risk of life-threatening blood or liver disorders and must be used carefully.

Sabril (vigabatrin) also has been used, but it can cause significant visual defects. It is not approved in the United States but is available in many other countries, including Canada, the UK, and Australia.

If high doses of seizure medicines are used to try to control frequent seizures, behavioral, social, and intellectual problems may worsen. This effect is especially likely if more than one medicine is used at the same time. Sometimes it's better to accept slightly more frequent seizures if it allows the child to be more alert and attentive, with a much better quality of life.

The ketogenic diet, vagus nerve stimulation (VNS), or a type of surgery called a corpus callosotomy can be helpful treatments for some patients. The ketogenic diet and the VNS have much lower risks, so patients generally try these approaches before considering callosotomy.

What's the outlook?

The course of the seizures varies greatly. Some children have fairly good seizure control later in life. Others grow up to have severe tonic seizures or drop attacks, and some develop partial and tonic-clonic seizures.

Children whose seizures come under fair to good control may have intellectual and behavioral development that approaches normal, but those with frequent seizures who are given high doses of more than one drug may be severely delayed. Both the child and the family often need support from a multidisciplinary medical and psychosocial team.

This syndrome usually continues through adulthood. Many affected people need to live in a residential (adult foster care) group home when their parents are no longer able to care for them.